ArticleCureus2025
Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) Management of Bullous Keratopathy After PreserFlo MicroShunt Device: A Case Report and Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bullous keratopathy is a known complication following glaucoma filtration surgeries, and Descemet's stripping automated endothelial keratoplasty (DSAEK) has been reported as an effective management approach in several cases. However, management of bullous keratopathy in eyes with minimally invasive bleb surgery (MIBS) devices presents unique challenges. We report the first successful case of DSAEK in a patient with bullous keratopathy following PreserFlo MicroShunt (PMS) (Santen Pharmaceutical Co., Ltd., Osaka, Japan) implantation, with additional complications of prior vitrectomy for malignant glaucoma. The patient, a 69-year-old male, had undergone bilateral pseudoexfoliative glaucoma surgery, and subsequent DSAEK was performed, resulting in favorable postoperative outcomes despite the challenging presentation. This case demonstrates the feasibility of endothelial keratoplasty in eyes with PreserFlo devices and crucial insights for surgical management, including our modified technique with limited central Descemet's membrane stripping, shortening of the PMS device, and utilization of a thinner donor graft to overcome the unique challenges associated with glaucoma drainage devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.